Fuso Pharmaceutical Industries,Ltd. (4538) Financial Statements

0 Followers

Fuso Pharmaceutical Industries,Ltd. Financial Overview

Fuso Pharmaceutical Industries,Ltd.'s market cap is currently ¥19.36B. The company's EPS TTM is ¥54.1; its P/E ratio is 10.03; and it has a dividend yield of 3.71%. Fuso Pharmaceutical Industries,Ltd. is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	¥ 62.31B	¥ 60.56B	¥ 55.41B	¥ 51.02B	¥ 49.63B
Gross Profit	¥ 15.99B	¥ 16.19B	¥ 13.52B	¥ 13.36B	¥ 12.91B
Operating Income	¥ 2.64B	¥ 4.13B	¥ 1.97B	¥ 2.21B	¥ 1.92B
EBITDA	¥ 5.26B	¥ 5.96B	¥ 3.69B	¥ 4.47B	¥ 4.30B
Net Income	¥ 2.01B	¥ -3.29B	¥ 1.38B	¥ 1.60B	¥ 1.48B
Balance Sheet
Cash & Short-Term Investments	¥ 4.85B	¥ 6.26B	¥ 5.12B	¥ 8.01B	¥ 7.35B
Total Assets	¥ 90.32B	¥ 82.52B	¥ 76.46B	¥ 72.81B	¥ 69.66B
Total Debt	¥ 28.46B	¥ 21.29B	¥ 12.72B	¥ 11.41B	¥ 12.09B
Net Debt	¥ 23.62B	¥ 15.03B	¥ 7.60B	¥ 3.40B	¥ 4.75B
Total Liabilities	¥ 55.26B	¥ 49.48B	¥ 39.79B	¥ 37.15B	¥ 35.12B
Stockholders' Equity	¥ 35.06B	¥ 33.04B	¥ 36.66B	¥ 35.65B	¥ 34.53B
Cash Flow
Free Cash Flow	¥ -7.49B	¥ -5.43B	¥ -2.62B	¥ 1.32B	¥ 2.20B
Operating Cash Flow	¥ -6.22B	¥ -3.31B	¥ 627.00M	¥ 2.87B	¥ 3.61B
Investing Cash Flow	¥ -1.51B	¥ -3.17B	¥ -3.54B	¥ -1.39B	¥ -1.66B
Financing Cash Flow	¥ 6.32B	¥ 7.62B	¥ 14.00M	¥ -813.00M	¥ -1.67B

Currency in JPY

Fuso Pharmaceutical Industries,Ltd. Earnings and Revenue History

Income Statement >

Fuso Pharmaceutical Industries,Ltd. Debt to Assets

Balance Sheet >

Fuso Pharmaceutical Industries,Ltd. Cash Flow

Cash Flow >

Fuso Pharmaceutical Industries,Ltd. Forecast EPS vs Actual EPS

Earnings >